Safety and efficacy of subcutaneous golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: final 5-year results of the GO-FORWARD trial

…, S Hall, SC Bae, C Han, TA Gathany… - The Journal of …, 2016 - jrheum.org
Objective. To evaluate the safety and efficacy of golimumab (GOL), a human antitumor
necrosis factor antibody, in patients with active rheumatoid arthritis (RA) despite methotrexate (…

The effect of golimumab therapy on disease activity and health-related quality of life in patients with ankylosing spondylitis: 2-year results of the GO-RAISE trial

…, J Braun, M Mack, B Hsu, TA Gathany… - The Journal of …, 2014 - jrheum.org
Objective. To evaluate the effects of golimumab therapy on achieving inactive disease or
major improvement, as assessed by the Ankylosing Spondylitis Disease Activity Score (ASDAS)…

[PDF][PDF] Efficacy and safety of subcutaneous golimumab in methotrexate‐naive patients with rheumatoid arthritis: Five‐year results of a randomized clinical trial

…, B Pons‐Estel, C Han, TA Gathany… - Arthritis Care & …, 2016 - Wiley Online Library
Objective To evaluate the safety and efficacy of golimumab through 5 years in adults with
active rheumatoid arthritis (RA) who had not previously received methotrexate (MTX). Methods …

The effect of intravenous golimumab on health-related quality of life in rheumatoid arthritis: 24-week results of the phase III GO-FURTHER trial

CO Bingham, M Weinblatt, C Han, TA Gathany… - The Journal of …, 2014 - jrheum.org
Objective. To evaluate the effects of intravenous (IV) golimumab 2 mg/kg + methotrexate (MTX)
on patient-reported measures of health-related quality of life (HRQOL) in patients with …

Involving students in problem solving

TA Gathany - The Mathematics Teacher, 1979 - pubs.nctm.org
Having students consider variations of a familiar problem can help to involve them in
problem solving and often leads to interesting new problems.

Changes in patient characteristics in anti-tumour necrosis factor clinical trials for rheumatoid arthritis: results of an analysis of the literature over the past 16 years

…, J Buchanan, MK Doyle, EC Hsia, T Gathany… - Annals of the …, 2011 - ard.bmj.com
Objective To evaluate changes in baseline patient characteristics and entry criteria of
randomised, controlled studies of tumour necrosis factor alpha (TNFα) inhibitors in rheumatoid …

Effect of golimumab on patient-reported outcomes in rheumatoid arthritis: results from the GO-FORWARD study

…, EC Hsia, J Buchanan, T Gathany… - The Journal of …, 2012 - jrheum.org
Objective. To evaluate the effect of golimumab on physical function, general health, and
fatigue in patients with active rheumatoid arthritis (RA) despite methotrexate (MTX) therapy. …

Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early …

…, C Pendley, D Baker, M Bala, T Gathany… - The Journal of …, 2007 - jrheum.org
OBJECTIVE: To determine if changes in biomarkers of inflammation and bone turnover in
response to treatment with infliximab plus methotrexate (MTX) versus MTX alone are …

Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized Placebo-Controlled Trial Of Golimumab In Patients With Active Rheumatoid Arthritis Despite Prior …

…, SC Bae, C Han, TA Gathany… - ARTHRITIS AND …, 2013 - repository.hanyang.ac.kr
Repository at Hanyang University: Final 5-Year Safety and Efficacy Results Of a Phase 3,
Randomized Placebo-Controlled Trial Of Golimumab In Patients With Active Rheumatoid Arthritis …

Comparative Efficacy of Adalimumab, Golimumab, and Infliximab in the Treatment of Patients with Ulcerative Colitis: An Induction Analysis: 1707

…, J Rizzo, MK Queener, T Gathany… - Official journal of the …, 2013 - journals.lww.com
Purpose: Adalimumab (ADA), golimumab (GLM), and infliximab (IFX) are anti-tumor necrosis
factor (anti-TNF) therapies approved for treating ulcerative colitis (UC). Clinical trials of …